Abstract
Purpose. Although pre-operative chemotherapy has improved the
prognosis for individuals with osteosarcoma, approximately 40% of patients will die of their
disease.The aim of this study was to quantitate proliferative activity in high grade
osteosarcomas and to determine whether proliferation is a prognostic factor.
Patients. The study consisted of 27 patients with high grade
non-metastatic osteosarcoma at various sites for whom pre-operative biopsies and
resection specimens were available for review. All patients were treated similarly and
had at least 24 months' follow-up from the date of diagnosis.
Methods. Proliferative activity (Ki-67 expression) was examined in the
diagnostic biopsies immunohistochemically using the MIB-1 antibody. Proliferation was
quantitated in two ways; (1) the number of immunopositive cells was counted manually
using an ocular grid; or (2) the percentage of immunopositive nuclear area was assessed
using morphometric image analysis. Proliferative index was evaluated in relation to
patient outcome.
Results. Proliferative activity was seen in all biopsies.The median
proliferative index as determined by counting cells was 24% (mean of 27%, range of 7–61%)
and by image analysis was 2% (mean 3%, range 0.32–8.4).The correlation between
MIB-1 proliferation indices determined either by image analysis methodology or manual cell
counting was high (Spearman's rho=0.79). Proliferative index did not appear to predict either
disease-free or overall survival.
Discussion. Tumor proliferation does not appear to be prognostic for
high grade osteosarcomas.Whether assessment of this feature in conjunction with other
tumor characteristics might be prognostic requires further study.